Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinxingmihuan
- Development stage
- Unknown
- Lead developer
- Tianyin Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Yinxingmihuan is a Chinese patent medicine formulated as an oral solution. It is primarily used for the treatment of coronary heart disease combined with anxiety (CHDCA), chest pain after percutaneous coronary intervention (PCI) in patients with stable angina, and has also been studied for ischemic stroke and cognitive risk syndromes. The main active ingredients are extracts from Ginkgo biloba leaves and Armillaria mellea powder. Its mechanism involves multiple biological processes including regulation of vascular smooth muscle contraction, angiogenesis, synaptic transmission in the nervous system, metabolism regulation, oxygen transport enhancement, hormone regulation, and estrogen synthesis. These actions contribute to improved cardiovascular function and potential anxiolytic effects[1][3][4].
- Brand names
- Yinxingmihuan
- Other names
- Ginkgo Leaf Extract and Armillariella Mellea Powder Oral SolutionGinkgo Leaf Extract/Armillariella Mellea Powder
02
Targets
IL1B (Interleukin-1 beta)VEGFA (Vascular endothelial growth factor A)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)
Beyond the preview
Go deeper on Yinxingmihuan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yinxingmihuan.